Impact of duration of maintenance immunotherapy on the prognosis of locally advanced non-small cell lung cancer treated with chemoradiotherapy
In patients with locally advanced non-small cell lung cancer who received consolidation immunotherapy after chemoradiotherapy, the number of cycles of immunotherapy was significantly associated with prognosis. These results need to be further validated in a large prospective study.
Authors
- Lujun Zhao
- Nan Bi (ORCID: https://orcid.org/0000-0001-7201-2930)
- Xue Li (ORCID: https://orcid.org/0000-0003-4988-4495)
- Jun Wang (ORCID: https://orcid.org/0000-0003-3941-2507)
- Song Guan
- Haiyan Fan (ORCID: https://orcid.org/0000-0002-0131-4592)
- Kai Ren (ORCID: https://orcid.org/0000-0002-9005-7590)
Institutions
- Hebei Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Tianjin Medical University Cancer Institute and Hospital (CN)
- National Cancer Center (US)
- Fourth Hospital of Hebei Medical University (CN)
- Beijing Chest Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-07-21
- DOI
- https://doi.org/10.3389/fonc.2025.1580396
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00